Create Free Account

By creating account you will get access to hot stocks & personalised emails

Respiri Ltd

Healthcare AU RSH

0.032AUD
-0.003(8.57%)

Last update at 2024-05-01T06:10:00Z

Day Range

0.030.03
LowHigh

52 Week Range

0.020.05
LowHigh

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Income before tax -5.77529M -6.62431M -11.04035M -7.26093M -7.46990M
Minority interest - - - - -
Net income -5.77529M -6.62431M -11.04035M -7.26093M -6.45815M
Selling general administrative 4.83M 3.77M 5.84M 5.91M 2.41M
Selling and marketing expenses 0.22M 0.92M 2.19M 0.78M 0.85M
Gross profit 0.00493M -0.00560M -0.99338M -0.99338M 1.03M
Reconciled depreciation 0.08M 0.08M 0.08M 0.01M 0.00463M
Ebit -5.76029M -7.07286M -12.16192M -9.46264M -8.48165M
Ebitda -5.68300M -6.99090M -12.08232M -9.45226M -8.47702M
Depreciation and amortization 0.08M 0.08M 0.08M 0.01M 0.00463M
Non operating income net other - - - - -
Operating income -5.76453M -6.63119M -11.09170M -9.46264M -8.48165M
Other operating expenses 6.29M 6.88M 9.90M 9.46M 8.48M
Interest expense 0.01M 0.45M 0.00000M 0.00000M 0.00000M
Tax provision 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Interest income 0.02M 0.08M 0.05M 0.00527M 0.02M
Net interest income -0.01500M - - 0.00166M 0.00514M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 0.61M -0.44854M -1.12157M -0.00166M -1.01175M
Total revenue 0.07M 0.25M 0.27M 0.27M 1.03M
Total operating expenses 6.36M 7.07M 11.17M 9.46M 8.48M
Cost of revenue 0.07M 0.26M 1.26M 1.26M -
Total other income expense net 0.59M 0.45M 1.12M 2.20M 1.01M
Discontinued operations - - - - -
Net income from continuing ops -5.77529M -6.62431M -11.04035M -7.26093M -8.47459M
Net income applicable to common shares -5.77529M -6.62431M -11.04035M -7.26093M -8.47459M
Preferred stock and other adjustments - - - - -
Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Total assets 3.18M 4.21M 9.11M 4.62M 1.01M
Intangible assets - - - - -
Earning assets - - - - -
Other current assets 1.42M 0.03M 0.11M 0.37M 0.01M
Total liab 2.35M 1.20M 1.54M 2.12M 2.58M
Total stockholder equity 0.83M 3.01M 7.57M 2.49M -1.56270M
Deferred long term liab - - - - -
Other current liab 0.63M 0.60M 0.31M 0.10M 0.01M
Common stock 132.10M 128.84M 127.09M 113.69M 106.04M
Capital stock 132.10M 128.84M 127.09M 113.69M 106.04M
Retained earnings -138.05254M -133.31255M -126.34628M -115.30594M -108.19186M
Other liab - - - 0.13M -0.03307M
Good will - - - - -
Other assets - - 0.00000M 0.00006M 0.00117M
Cash 0.15M 1.22M 7.97M 3.55M 0.31M
Cash and equivalents - - 7.97M - -
Total current liabilities 2.24M 1.20M 1.47M 2.00M 2.58M
Current deferred revenue 0.06M 0.00316M 0.00086M 0.26M 0.23M
Net debt 0.00297M -1.14661M -7.83072M -2.65945M 0.50M
Short term debt 0.03M 0.07M 0.07M 0.76M 0.81M
Short long term debt - - - 0.72M 0.81M
Short long term debt total 0.15M 0.07M 0.14M 0.89M 0.81M
Other stockholder equity -0.00055M 7.48M -0.74412M 4.11M 1.59M
Property plant equipment 0.18M 0.08M 0.16M 0.19M 0.00950M
Total current assets 3.00M 4.12M 8.95M 4.43M 1.00M
Long term investments - - - - -
Net tangible assets 0.83M 3.01M 7.57M 2.49M -1.56270M
Short term investments 0.03M 0.03M 0.54M 0.05M 0.05M
Net receivables 0.05M 0.05M 0.14M 0.00820M 0.16M
Long term debt - 0.00000M - - -
Inventory 1.23M 2.65M 0.54M 0.31M 0.52M
Accounts payable 1.51M 0.52M 1.08M 0.87M 1.53M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 6.78M 7.48M 6.83M 4.11M 0.59M
Additional paid in capital - - - - -
Common stock total equity - - - 113.69M 106.04M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other -0.17633M -0.08269M 0.50M 0.00006M 0.00117M
Deferred long term asset charges - - - - -
Non current assets total 0.18M 0.08M 0.16M 0.19M 0.01M
Capital lease obligations 0.15M 0.07M 0.14M 0.18M -
Long term debt total 0.12M 0.00000M 0.07M 0.13M 0.00000M
Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Investments -0.02180M -0.00227M -0.05425M -0.01286M -0.00318M
Change to liabilities 1.12M -0.50270M 0.16M -0.62567M 0.76M
Total cashflows from investing activities -0.02180M -0.00227M -0.05425M -0.01286M -0.00318M
Net borrowings 0.20M 0.20M -0.74452M -0.14681M 0.80M
Total cash from financing activities 3.46M 1.64M 11.79M 7.96M 4.33M
Change to operating activities -0.29606M 0.26M 0.23M -0.02555M -0.42306M
Net income -5.77529M -6.62431M -11.04035M -7.26093M -8.47459M
Change in cash -1.07111M -6.75592M 4.42M 3.25M -2.11177M
Begin period cash flow 1.22M 7.97M 3.55M 0.31M 2.42M
End period cash flow 0.15M 1.22M 7.97M 3.55M 0.31M
Total cash from operating activities -4.49019M -8.47758M -7.33910M -4.68796M -6.41132M
Issuance of capital stock 3.65M 1.67M 13.08M 8.53M 3.75M
Depreciation 0.08M 0.08M 0.08M 0.01M 0.00463M
Other cashflows from investing activities - - - - 0.00000M
Dividends paid - - 11.79M 7.96M 0.15M
Change to inventory 0.03M -2.11407M -0.22783M -0.30922M -0.30922M
Change to account receivables 0.00306M 0.09M -0.05779M 0.15M -0.04281M
Sale purchase of stock -0.39133M -0.03307M -0.54735M -0.42538M -0.21800M
Other cashflows from financing activities 0.20M -0.00227M -0.05425M -0.01286M 1.09M
Change to netincome 0.35M 0.34M 3.51M 3.37M 1.76M
Capital expenditures 0.02M 0.00227M 0.05M 0.01M 0.00318M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 0.03M -2.02839M -0.28561M -0.15585M 1.03M
Stock based compensation 0.34M 0.42M 3.53M 3.27M -
Other non cash items 1.21M -1.93522M 3.62M 2.56M 8.47M
Free cash flow -4.51199M -8.47985M -7.39335M -4.70082M -6.41450M

Fundamentals

  • Previous Close 0.04
  • Market Cap38.16M
  • Volume773159
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-6.24850M
  • Revenue TTM0.79M
  • Revenue Per Share TTM0.001
  • Gross Profit TTM 0.59M
  • Diluted EPS TTM-0.01

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
RSH
Respiri Ltd		 -0.003 8.57% 0.03 - 1.13 42.95 10.23 344.53 -6.3052
COH
Cochlear Ltd		 -7.93 2.44% 317.17 60.87 46.30 9.75 11.76 9.62 36.63
PNV
Polynovo Ltd		 -0.04 1.95% 2.01 - 140.85 17.37 21.49 17.51 647.42
AVR
Anteris Technologies Ltd		 -0.2 0.91% 21.70 - - 104.23 14.98 95.15 -5.9152
AVH
Avita Therapeutics Inc		 -0.06 2.23% 2.63 - - 8.59 5.71 6.72 -10.0538

Reports Covered

Stock Research & News

View All

Profile

Respiri Limited, an e-health SaaS company, researches, develops, and commercializes medical devices in Australia. The company develops, produces, and sells mobile health applications. Its products include wheezo, an electronic wheeze detection tool to detect wheeze in children; respiri mobile application; and Respiri health portal. The company was formerly known as iSonea Limited and changed its name to Respiri Limited in December 2015. The company is based in Melbourne, Australia.

Respiri Ltd

432 St Kilda Road, Melbourne, VIC, Australia, 3004

Key Executives

Name Title Year Born
Mr. Nicholas Smedley Exec. Chairman NA
Mr. Marjan Mikel B.Sc., M.A.I.C.D. CEO, MD & Exec. Director NA
Mr. George Vlachodimitropoulos Chief Technology Officer NA
Mr. Theo Antonopoulos Chief Commercial Officer NA
Mr. Andrew Metcalfe CPA Company Sec. NA
Prof. Noam Gavriely Medical & Scientific Advisor NA
Mr. Simon Godfrey Medical & Scientific Advisor NA
Mr. Philippe Ludekens Gen. Mang. of Commercial Operations NA
Mr. Nicholas Smedley Executive Chairman NA
Mr. Marjan Mikel B.Sc., M.A.I.C.D. CEO, MD & Executive Director NA

Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).

Our Company

Useful Links

Contact Us

Market Research

Our Company

Useful Links

Contact Us

Disclaimer

The information given by Kalkine Pty Ltd ABN34 154 808 312 (Australian Financial Services License Number 425376) on this website is general information or advice only.

It does not take into account any of your personal objectives, circumstances or needs. Choosing an investment is an important decision. If you do not feel confident making a decision based on the recommendations Kalkine has made in our reports, you should consider obtaining personal advice from an authorised adviser.

There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. Terms & Conditions have been provided for our services, please go through them and also read our Financial Services Guide.

Our website may contain information on past performance of particular investments. Past performance is not an indicator of future performance. Hypothetical returns may not reflect actual performance. Any displays of potential investment opportunities are for sample purposes only and may not actually be available to investors.

The information on the website does not constitute an offer to sell securities or a solicitation of an offer to buy securities. Our reports contain general recommendations to invest in securities.

Copyright 2024 Krish Capital Pty. Ltd. All rights reserved. No part of this website, or its content, may be reproduced in any form without our prior consent.